RBC Capital downgraded Celgene (NASDAQ: CELG) from Top Pick to Outperform with a price target of $118.00 (from $120.00).Analyst Brian ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE